These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

312 related items for PubMed ID: 28919541

  • 1. Drugs for Treating Opioid-Induced Constipation: A Mixed Treatment Comparison Network Meta-analysis of Randomized Controlled Clinical Trials.
    Sridharan K, Sivaramakrishnan G.
    J Pain Symptom Manage; 2018 Feb; 55(2):468-479.e1. PubMed ID: 28919541
    [Abstract] [Full Text] [Related]

  • 2. Evidence Based Review of Pharmacotherapy for Opioid-Induced Constipation in Noncancer Pain.
    Murphy JA, Sheridan EA.
    Ann Pharmacother; 2018 Apr; 52(4):370-379. PubMed ID: 29092627
    [Abstract] [Full Text] [Related]

  • 3. Efficacy of Treatments for Opioid-Induced Constipation: Systematic Review and Meta-analysis.
    Nee J, Zakari M, Sugarman MA, Whelan J, Hirsch W, Sultan S, Ballou S, Iturrino J, Lembo A.
    Clin Gastroenterol Hepatol; 2018 Oct; 16(10):1569-1584.e2. PubMed ID: 29374616
    [Abstract] [Full Text] [Related]

  • 4. Efficacy of methylnaltrexone for the treatment of opiod-induced constipation: a meta-analysis and systematic review.
    Mehta N, O'Connell K, Giambrone GP, Baqai A, Diwan S.
    Postgrad Med; 2016 Oct; 128(3):282-9. PubMed ID: 26839023
    [Abstract] [Full Text] [Related]

  • 5. The Management of Opioid-Induced Constipation in Cancer and Advanced Illness: A Meta-Analysis.
    Jesuyajolu DA, Abubakar AK, Kowe T, Ogunlade S, Abioye AI, Tangeman J, Latuga N, Omotayo MO.
    J Pain Symptom Manage; 2024 Apr; 67(4):e285-e297. PubMed ID: 38092261
    [Abstract] [Full Text] [Related]

  • 6. Systematic review with meta-analysis: efficacy and safety of treatments for opioid-induced constipation.
    Vijayvargiya P, Camilleri M, Vijayvargiya P, Erwin P, Murad MH.
    Aliment Pharmacol Ther; 2020 Jul; 52(1):37-53. PubMed ID: 32462777
    [Abstract] [Full Text] [Related]

  • 7. Efficacy and Tolerability of Subcutaneous Methylnaltrexone in Patients with Advanced Illness and Opioid-Induced Constipation: A Responder Analysis of 2 Randomized, Placebo-Controlled Trials.
    Nalamachu SR, Pergolizzi J, Taylor R, Slatkin NE, Barrett AC, Yu J, Bortey E, Paterson C, Forbes WP.
    Pain Pract; 2015 Jul; 15(6):564-71. PubMed ID: 24815199
    [Abstract] [Full Text] [Related]

  • 8. Efficacy of pharmacological therapies for the treatment of opioid-induced constipation: systematic review and meta-analysis.
    Ford AC, Brenner DM, Schoenfeld PS.
    Am J Gastroenterol; 2013 Oct; 108(10):1566-74; quiz 1575. PubMed ID: 23752879
    [Abstract] [Full Text] [Related]

  • 9. Novel Oral Therapies for Opioid-induced Bowel Dysfunction in Patients with Chronic Noncancer Pain.
    Holder RM, Rhee D.
    Pharmacotherapy; 2016 Mar; 36(3):287-99. PubMed ID: 26945548
    [Abstract] [Full Text] [Related]

  • 10. Phase IIb, Randomized, Double-Blind, Placebo-Controlled Study of Naldemedine for the Treatment of Opioid-Induced Constipation in Patients With Cancer.
    Katakami N, Oda K, Tauchi K, Nakata K, Shinozaki K, Yokota T, Suzuki Y, Narabayashi M, Boku N.
    J Clin Oncol; 2017 Jun 10; 35(17):1921-1928. PubMed ID: 28445097
    [Abstract] [Full Text] [Related]

  • 11. Randomized, Double-Blind Trial of Oral Methylnaltrexone for the Treatment of Opioid-Induced Constipation in Patients with Chronic Noncancer Pain.
    Rauck R, Slatkin NE, Stambler N, Harper JR, Israel RJ.
    Pain Pract; 2017 Jul 10; 17(6):820-828. PubMed ID: 27860208
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Laxatives or methylnaltrexone for the management of constipation in palliative care patients.
    Candy B, Jones L, Goodman ML, Drake R, Tookman A.
    Cochrane Database Syst Rev; 2011 Jan 19; (1):CD003448. PubMed ID: 21249653
    [Abstract] [Full Text] [Related]

  • 14. Efficacy of naldemedine for the treatment of opioid-induced constipation: A meta-analysis.
    Esmadi M, Ahmad D, Hewlett A.
    J Gastrointestin Liver Dis; 2019 Mar 19; 28(1):41-46. PubMed ID: 30851171
    [Abstract] [Full Text] [Related]

  • 15. A meta-analysis of naldemedine for the treatment of opioid-induced constipation.
    Song X, Wang D, Qu X, Dong N, Teng S.
    Expert Rev Clin Pharmacol; 2019 Feb 19; 12(2):121-128. PubMed ID: 30652502
    [Abstract] [Full Text] [Related]

  • 16. Efficacy and Safety of Peripherally Acting Mu-Opioid Receptor Antagonists for the Treatment of Opioid-Induced Constipation: A Bayesian Network Meta-analysis.
    Ouyang R, Li Z, Huang S, Liu J, Huang J.
    Pain Med; 2020 Nov 01; 21(11):3224-3232. PubMed ID: 32488259
    [Abstract] [Full Text] [Related]

  • 17. Naldemedine: First Global Approval.
    Markham A.
    Drugs; 2017 May 01; 77(8):923-927. PubMed ID: 28466424
    [Abstract] [Full Text] [Related]

  • 18. Pharmacological Treatment of Opioid-Induced Constipation Is Effective but Choice of Endpoints Affects the Therapeutic Gain.
    Nusrat S, Syed T, Saleem R, Clifton S, Bielefeldt K.
    Dig Dis Sci; 2019 Jan 01; 64(1):39-49. PubMed ID: 30284134
    [Abstract] [Full Text] [Related]

  • 19. New Options in Constipation Management.
    Davis M, Gamier P.
    Curr Oncol Rep; 2015 Dec 01; 17(12):55. PubMed ID: 26449843
    [Abstract] [Full Text] [Related]

  • 20. Long-term use of naldemedine in the treatment of opioid-induced constipation in patients with chronic noncancer pain: a randomized, double-blind, placebo-controlled phase 3 study.
    Webster LR, Nalamachu S, Morlion B, Reddy J, Baba Y, Yamada T, Arjona Ferreira JC.
    Pain; 2018 May 01; 159(5):987-994. PubMed ID: 29419653
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.